drugset / Trial / NCT02837952

A Study of Ibuprofen (IBU) 250mg/APAP 500mg In The Treatment Of Post-Surgical Dental Pain

NCT02837952

Phase 3 Completed 123 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is being conducted to determine the overall analgesic efficacy and safety of a fixed-dose ibuprofen 250 mg / acetaminophen 500 mg formulation compared to placebo in subjects who are experiencing post operative pain following surgical extraction of 3 or more third molar teeth. A review of any reported adverse events will also be completed.

Timeline

Start
2016-08-31
Primary completion
2017-02-01
Completion
2017-02-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetaminophen Small molecule 500 mg
Comparator Ibuprofen Small molecule 250 mg

Indications

No indication recorded.